EVX Ventures and Boehringer Ingelheim Venture Fund Lead USD24m Series A for Singaporean Biotech Nuevocor
Source(s): Fierce Biotech
EVX Ventures and Boehringer Ingelheim Venture Fund led a USD24m Series A for Nuevocor, a Singapore-based developer of cardiac gene therapies, with participation from EDBI, Xora Innovation and SEEDS Capital. Read more